BORSINI, F., VOLTERRA, G., MELI. A. 1986. Does the behavioral "despair" test measure "despair"? Physiology and Behavior 38: 385–386.
BARLOW, D.H., DURAND, V.M. 2005. Abnormal Psychology: An Integrative Approach , 5th edition, Belmont, CA, USA: Thomson Wadsworth, pp. 248.
BERDOY, M., WEBSTER, J.P., MACDONALD, D.W. 2000. Fatal attraction in rats infected with
Toxoplasma gondii.
Proceding, Biological Sciences/The royal Society 267:1591–1594.
BROWN, C.R., HUNTER, C.A., ESTES, R.G., BECKMANN, E., FORMAN, J., DAVID, C., REMINGTON, J.S., MCLEOD, R. 1995. Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis. Immunology 85: 419–428.
CARRUTHERS, V.B., SUZUKI, Y. 2007. Effects of Toxoplasma gondii infection on the brain.Schizophrenia Bulletin 33:745–751.
DUPONT, C.D., CHRISTIAN, D.A., HUNTER, C.A. 2012. "Immune response and immunopathology during toxoplasmosis". Seminal Immunopathology 34: 793.
DÄUBENER, W., WANAGAT, N., PILZ K., SEGHROUCHNI, S., FISCHER, H.G., HADDING, U. 1994. A new, simple, bioassay for human IFN-gamma. Journal of Immunological Methods 168: 39–47.
FUJIGAKI, S., SAITO, K., TAKEMURA, M., MAEKAWA, N., YAMADA, Y., WADA, H., SEISHIMA, M. 2002. L-Tryptophan-l-Kynurenine Pathway Metabolism Accelerated by Toxoplasma gondii Infection Is Abolished in Gamma Interferon-Gene-Deficient Mice: Cross-Regulation between Inducible Nitric Oxide Synthase and Indoleamine-2, 3-Dioxygenase. Infection and Immunity 70: 779–786.
FUKUI,S., SCHWARCZ, R., RAPOPORT, S.I., TAKADA, Y., SMITH, Q.R.1991. Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism. Journal of Neurochemistry. 56: 2007
–2017.
KIM, H., CHEN, L., LIM, G., SUNG, B., WANG, S., MCCABE, M.F., RUSANESCU, G., YANG, L., TIAN, Y., MAO, J. 2012. Brain indoleamine 2, 3-dioxygenase contributes to the comorbidity of pain and depression. Journal of Clinical Investigation. 122: 2940
–2954.
LESTAGE, J., VERRIER, D., PALIN, K., DANTZER, R. 2002. The enzyme indoleamine 2, 3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen.
Brain, Behavior and Immunity 16: 596
–601.
LING, V, J., LESTER, D., MORTENSEN, P.B., LANGENBERG, P.W., POSTOLACHE, T.T. 2011."Toxoplasma gondii Seropositivity and Suicide rates in Women". Journal of Nervous and Mental Disorders 199: 440–444
LYONS, R. E., MCLEOD, R., ROBERTS, C.W. 2002 Toxoplasma gondii tachyzoite- bradyzoite interconversion. Trends in Parasitology. 18:198–201.
MAHMOUD, M.E., Ihara, F., Fereig, R.M., NISHIMURA, M., Y. NISHIKAWA. 2016. Induction of depression-related behaviors by reactivation of chronic Toxoplasma gondii infection in mice. Behavioral Brain Research 298: 125–133.
MAHMOUD, M.E., F., SALMAN, D., NISHIMURA, Y.NISHIKAWA, M. 2015. Mechanisms of interferon-beta-induced inhibition of T. gondii growth in murine macrophages and embryonic fibroblasts: role of immunity-related GTPaseM1.Cellular Microbiol.17:1069.
MONTOYA, J.G., LIESENFELD, O. 2004. "Toxoplasmosis". Lancet 363: 1965–1976.
MÜLLER, N. 1997. Role of the cytokine network in the CNS and psychiatric disorders. Der
Nervenarzt 68:11.
NIELSEN, C.K., ARNT, J., SÁNCHEZ, C. 2000. Intracranial self-stimulation and sucrose intake differ as hedonic measures following chronic mild stress interstrain and interindividual differences. Behavioral Brain Research 107: 21–33.
O'CONNOR, J., C., ANDRÉ, C., WANG, Y., LAWSON, M.A., SZEGEDI, LESTAGE, S.S, J. 2009a. Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2, 3-dioxygenase and the induction of depressive-like behavior in mice response to bacillus Calmette–Guérin. Journal of Neuroscience. 29: 4200
–4209.
O'CONNOR, J.C, ANDRÉ, C., WANG, Y., LAWSON, M.A., SZEGEDI, S.S., LESTAGE, J., CASTANON N, KELLEY, K.W., DANTZER, R. 2009b. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2, 3-dioxygenase activation in mice. Molecular Psychiatry 14: 511–522.
OXENKRUG, G. 2013. Serotonin-kynurenine hypothesis of depression: historical overview and recent developments. Current Drug Targets.14: 514–521.
PEARCE, B.D., KRUSZON-MORAN, D., . JONES, J.L. 2012. The relationship between Toxoplasma gondii infection and mood disorders in the third National Health and Nutrition Survey. Biological Psychiatry 72: 290–295
PEDERSEN, M.G., MORTENSEN, P.B., NORGAARD-PEDERSEN, B., POSTOLACHE, T.T. 2012. "Toxoplasma gondii infection and self-directed violence in mothers". Archive of General Psychiatry 69: 1123.
RUSSO, S., KEMA, I.P., FOKKEMA, M.R., BOON, J.C., WILLEMSE, P.H., DE, VRIES E.G., DEN BOER, J.A., KORF, J. 2003. Tryptophan as a link between psychopathology and somatic states.
Psychosomatic Medicine 65: 665
–671.
STREKALOVA, T., SPANAGEL, R., BARTSCH, D., HENN, F.A., GASS, P. 2002..Stress-induced anhedonia in mice is associated with deficits in forced swimming and exploration
. Neuropsycho-pharmacology. 29:2007–2017.
SUZUKI, Y., KANG, H., PARMLEY, S., LIM, S., PARK, D. 2000. Induction of tumor necrosis factor-alpha and inducible nitric oxide synthase fails to prevent toxoplasmic encephalitis in the absence of interferon-gamma in genetically resistant BALB/c mice. Microbes and Infection 2: 455–462.
SUZUKI, Y., YANG, Q., REMINGTON, J.S. 1995.Genetic resistance against acute toxoplasmosis depends on the strain of T. gondii. Journal of Parasitology 81: 1032.
WICHERS, M.C., KOEK, G.H., ROBAEYS, G., VERKERK, R., SCHARPÉ, S., MAESM. 2005. IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity. Molecular Psychiatry. 10: 538
–544.
ZHANG, Y., TRÄSKMAN-BENDZ, L., JANELIDZE, S., LANGENBERG, P., SALEH, A., CONSTANTINE, N. 2012. Toxoplasma gondii immunoglobulin G antibodies and nonfatal suicidal self-directed violence. Journal of Clinical Psychiatry. 73:1069–1076.